Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):e165-72. doi: 10.1016/j.ijrobp.2012.10.038. Epub 2012 Dec 19.
Proton beam therapy (PBT) centers have drawn increasing public scrutiny for their high cost. The behavior of such facilities is likely to change under the Affordable Care Act. We modeled how accountable care reform may affect the financial standing of PBT centers and their incentives to treat complex patient cases.
We used operational data and publicly listed Medicare rates to model the relationship between financial metrics for PBT center performance and case mix (defined as the percentage of complex cases, such as pediatric central nervous system tumors). Financial metrics included total daily revenues and debt coverage (daily revenues - daily debt payments). Fee-for-service (FFS) and accountable care (ACO) reimbursement scenarios were modeled. Sensitivity analyses were performed around the room time required to treat noncomplex cases: simple (30 minutes), prostate (24 minutes), and short prostate (15 minutes). Sensitivity analyses were also performed for total machine operating time (14, 16, and 18 h/d).
Reimbursement under ACOs could reduce daily revenues in PBT centers by up to 32%. The incremental revenue gained by replacing 1 complex case with noncomplex cases was lowest for simple cases and highest for short prostate cases. ACO rates reduced this incremental incentive by 53.2% for simple cases and 41.7% for short prostate cases. To cover daily debt payments after ACO rates were imposed, 26% fewer complex patients were allowable at varying capital costs and interest rates. Only facilities with total machine operating times of 18 hours per day would cover debt payments in all scenarios.
Debt-financed PBT centers will face steep challenges to remain financially viable after ACO implementation. Paradoxically, reduced reimbursement for noncomplex cases will require PBT centers to treat more such cases over cases for which PBT has demonstrated superior outcomes. Relative losses will be highest for those facilities focused primarily on treating noncomplex cases.
质子束治疗(PBT)中心因其高昂的成本而受到越来越多的公众关注。在《平价医疗法案》下,这些设施的行为可能会发生变化。我们构建了模型来研究问责制医疗改革可能如何影响 PBT 中心的财务状况及其治疗复杂病例的积极性。
我们使用运营数据和公开上市的医疗保险费率来模拟 PBT 中心绩效和病例组合(定义为复杂病例的百分比,如儿科中枢神经系统肿瘤)的财务指标之间的关系。财务指标包括每日总收入和债务覆盖(每日收入-每日债务支付)。模拟了按服务收费(FFS)和问责制医疗(ACO)报销方案。围绕治疗非复杂病例所需的治疗室时间(简单病例 30 分钟、前列腺病例 24 分钟和短前列腺病例 15 分钟)进行了敏感性分析。还对总机器运行时间(14、16 和 18 小时/天)进行了敏感性分析。
在 ACO 下的报销可能会使 PBT 中心的每日收入减少高达 32%。用非复杂病例取代 1 个复杂病例所获得的增量收入,对于简单病例来说最低,对于短前列腺病例来说最高。ACO 费率将简单病例的增量激励降低了 53.2%,将短前列腺病例的增量激励降低了 41.7%。在实施 ACO 费率后,为了支付每日债务,允许的复杂患者数量将减少 26%,具体取决于资本成本和利率的不同。只有每天运行机器 18 小时的设施才能在所有方案中支付债务。
在实施 ACO 后,债务融资的 PBT 中心将面临严峻的财务生存挑战。矛盾的是,非复杂病例的报销减少将要求 PBT 中心治疗更多此类病例,而不是那些 PBT 已证明具有更好疗效的病例。对于那些主要专注于治疗非复杂病例的设施来说,相对损失将是最高的。